{"name":"Joint Authority for Päijät-Häme Social and Health Care","slug":"joint-authority-for-p-ij-t-h-me-social-and-health-care","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"Methyl 5-aminolevulinate","genericName":"Methyl 5-aminolevulinate","slug":"methyl-5-aminolevulinate","indication":"Other","status":"marketed"},{"name":"Methylaminolevulinate cream","genericName":"Methylaminolevulinate cream","slug":"methylaminolevulinate-cream","indication":"Other","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BF-200 ALA cream","genericName":"BF-200 ALA cream","slug":"bf-200-ala-cream","indication":"Actinic keratosis (field treatment)","status":"marketed"}]}],"pipeline":[{"name":"BF-200 ALA cream","genericName":"BF-200 ALA cream","slug":"bf-200-ala-cream","phase":"marketed","mechanism":"BF-200 ALA cream is a photodynamic therapy agent that uses aminolevulinic acid to generate reactive oxygen species upon light activation, destroying abnormal skin cells.","indications":["Actinic keratosis (field treatment)","Non-melanoma skin cancer (basal cell carcinoma, squamous cell carcinoma)"],"catalyst":""},{"name":"Methyl 5-aminolevulinate","genericName":"Methyl 5-aminolevulinate","slug":"methyl-5-aminolevulinate","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Methylaminolevulinate cream","genericName":"Methylaminolevulinate cream","slug":"methylaminolevulinate-cream","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":3,"phaseCounts":{"marketed":3},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}